JOSEPH LOSCALZO - Corporate Board Profile

IONIS PHARMACEUTICALS INC

Filing Date	Source Excerpt
2018-04-11	Joseph Loscalzo, age 66, is Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital. Dr. Loscalzo received his A.B. degree, summa cum laude, his Ph.D. in biochemistry, and his M.D. from the University of Pennsylvania. His clinical training was completed at Brigham and Women’s Hospital and Harvard Medical School, where he served as Resident and Chief Resident in medicine and Fellow in cardiovascular medicine. Post-training, Dr. Loscalzo joined the Harvard faculty and staff at Brigham and Women’s Hospital in 1984. He rose to the rank of Associate Professor of Medicine, Chief of Cardiology at the West Roxbury Veterans Administration Medical Center, and Director of the Center for Research in Thrombolysis at Brigham and Women’s Hospital. He joined the faculty of Boston University in 1994, first as Chief of Cardiology and, in 1997, Wade Professor and Chair of Medicine, Professor of Biochemistry, and Director of the Whitaker Cardiovascular Institute. He returned to Harvard and Brigham and Women’s Hospital in 2005. He currently serves on the board of directors of Leap Therapeutics, Inc., a publicly held biopharmaceutical company. The Board believes Dr. Loscalzo is uniquely suited to serve on the Board primarily because of his extensive scientific expertise, including 27 years of research in the areas of vascular biology, thrombosis, and atherosclerosis, and practical knowledge as a practicing physician. Dr. Loscalzo’s expertise and role as a leading cardiologist is particularly valuable as we advance and grow our cardiovascular franchise. In 2017, Mr. Loscalzo received $75,000 in cash compensation and stock and option awards with an aggregate fair value of $636,941.
2019-04-26	Joseph Loscalzo, M.D., Ph.D., age 67, has served as a Director of Ionis since February 2014. ... The Board believes that Dr. Loscalzo is uniquely suited to serve on the Board primarily because of his extensive scientific expertise, including 28 years of research in the areas of vascular biology, thrombosis, and atherosclerosis, and practical knowledge as a practicing physician.
2020-04-24	Director Compensation for Fiscal 2019 Joseph Loscalzo Cash Compensation Earned or Paid ($): $75,000 Stock Awards ($): $460,728 Option Awards ($): $607,645 Total ($): $1,143,373
2021-04-23	Joseph Loscalzo, M.D., Ph.D., age 69, has served as a Director of Ionis since February 2014. ... Director Compensation for Fiscal 2020 ... Joseph Loscalzo ... Total ($) $800,331.
2022-04-20	Joseph Loscalzo, M.D., Ph.D., age 70, has served as a Director of Ionis since February 2014 and as Chairman of the Board since June 2021. ... Dr. Loscalzo is Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School and Chairman of the Department of Medicine and Physician-in-Chief at Brigham and Women’s Hospital. ... The Board believes Dr. Loscalzo is uniquely suited to serve on the Board and as our Chairman primarily because of his extensive scientific expertise, including 31 years of research in the areas of vascular biology, thrombosis, and atherosclerosis, and practical knowledge as a practicing physician. ... The table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of our Directors: ... Joseph Loscalzo: Cash Compensation $101,250, Stock Awards $213,587, Option Awards $273,240, Total $588,077.
2024-04-25	Joseph Loscalzo, M.D., Ph.D., age 72, has served as a Director of Ionis since February 2014 and as Chairman of the Board since June 2021. Dr. Loscalzo serves on the Nominating, Governance and Review and Medical and Science Committees. Dr. Loscalzo received total compensation of $568,038 in 2023.